Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$25.72 - $29.94 $15,020 - $17,484
-584 Reduced 0.85%
68,126 $1.85 Million
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $68,409 - $92,712
2,921 Added 4.44%
68,710 $2.13 Million
Q3 2023

Nov 13, 2023

BUY
$19.86 - $26.93 $46,472 - $63,016
2,340 Added 3.69%
65,789 $1.66 Million
Q2 2023

Aug 04, 2023

SELL
$16.44 - $21.1 $29,493 - $37,853
-1,794 Reduced 2.75%
63,449 $1.34 Million
Q1 2023

May 12, 2023

BUY
$16.26 - $21.73 $21,105 - $28,205
1,298 Added 2.03%
65,243 $1.11 Million
Q4 2022

Feb 10, 2023

BUY
$16.98 - $23.15 $124,429 - $169,643
7,328 Added 12.94%
63,945 $1.28 Million
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $16,704 - $22,568
800 Added 1.43%
56,617 $1.22 Million
Q2 2022

Aug 12, 2022

SELL
$17.07 - $25.71 $48,137 - $72,502
-2,820 Reduced 4.81%
55,817 $1.1 Million
Q1 2022

May 13, 2022

SELL
$20.42 - $28.13 $84,273 - $116,092
-4,127 Reduced 6.58%
58,637 $1.38 Million
Q4 2021

Feb 11, 2022

SELL
$25.89 - $33.45 $4,427 - $5,719
-171 Reduced 0.27%
62,764 $1.71 Million
Q3 2021

Nov 12, 2021

BUY
$22.46 - $29.47 $114,006 - $149,589
5,076 Added 8.77%
62,935 $1.73 Million
Q2 2021

Aug 13, 2021

SELL
$24.17 - $36.01 $164,452 - $245,012
-6,804 Reduced 10.52%
57,859 $1.65 Million
Q1 2021

May 07, 2021

SELL
$32.28 - $44.3 $19,174 - $26,314
-594 Reduced 0.91%
64,663 $2.2 Million
Q4 2020

Feb 12, 2021

BUY
$31.45 - $40.54 $148,286 - $191,146
4,715 Added 7.79%
65,257 $2.17 Million
Q3 2020

Nov 04, 2020

SELL
$26.0 - $34.5 $35,776 - $47,472
-1,376 Reduced 2.22%
60,542 $1.95 Million
Q2 2020

Aug 12, 2020

BUY
$14.11 - $29.42 $129,868 - $270,781
9,204 Added 17.46%
61,918 $1.71 Million
Q1 2020

May 04, 2020

SELL
$13.63 - $33.98 $41,503 - $103,469
-3,045 Reduced 5.46%
52,714 $845,000
Q4 2019

Feb 05, 2020

SELL
$16.12 - $24.98 $7,560 - $11,715
-469 Reduced 0.83%
55,759 $1.33 Million
Q3 2019

Nov 08, 2019

BUY
$15.49 - $25.78 $107,392 - $178,732
6,933 Added 14.06%
56,228 $992,000
Q2 2019

Aug 13, 2019

BUY
$23.0 - $32.19 $10,603 - $14,839
461 Added 0.94%
49,295 $1.26 Million
Q1 2019

May 06, 2019

SELL
$13.91 - $31.15 $22,005 - $49,279
-1,582 Reduced 3.14%
48,834 $1.42 Million
Q4 2018

Feb 13, 2019

SELL
$11.6 - $18.7 $4,512 - $7,274
-389 Reduced 0.77%
50,416 $661,000
Q3 2018

Nov 09, 2018

BUY
$18.95 - $28.08 $17,377 - $25,749
917 Added 1.84%
50,805 $1.03 Million
Q2 2018

Aug 08, 2018

BUY
$20.0 - $29.72 $19,580 - $29,095
979 Added 2.0%
49,888 $1.18 Million
Q1 2018

May 07, 2018

SELL
$21.69 - $32.99 $57,044 - $86,763
-2,630 Reduced 5.1%
48,909 $1.1 Million
Q4 2017

Feb 09, 2018

BUY
$26.43 - $31.78 $59,599 - $71,663
2,255 Added 4.58%
51,539 $1.61 Million
Q3 2017

Nov 09, 2017

BUY
$11.61 - $31.21 $572,187 - $1.54 Million
49,284
49,284 $1.54 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.48B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.